Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2026-02-21 @ 11:35 PM
Study NCT ID:
NCT03257761
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-05
First Post:
2017-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-08-19
First Submit QC Date:
None
Study First Post Date:
2017-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED